Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 16 Jul 21 EFFECT Notice of effectiveness
- 15 Jul 21 424B3 Prospectus supplement
- 13 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
1 Jul 21 S-4 Registration of securities issued in business combination transactions
ACST similar filings
- 31 Jul 24 Registration of securities issued in business combination transactions (amended)
- 27 Jun 24 Registration of securities issued in business combination transactions
- 13 Jul 21 Registration of securities issued in business combination transactions (amended)
- 1 Jul 21 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.3
Consent to be Named as a Director Nominee
In connection with the filing by Acasti Pharma Inc., of the Registration Statement on Form S-4 with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of Acasti Pharma Inc., in the Registration Statement and any and all amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendments thereto.
/s/ William A. Haseltine |
William A. Haseltine |
June 30, 2021